Virtu Financial LLC Kamada LTD Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Dec 11, 2020	SELL	$8.02 - $11.73 $167,537 - $245,039	-20,890 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$5.37 - $9.45 $112,179 - $197,410	20,890 New	20,890 $162,000
Q4 2017 Feb 09, 2018	SELL	$4.35 - $5.15 $90,627 - $107,295	-20,834 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$4.25 - $4.8 $88,544 - $100,003	20,834	20,834 $0

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $260M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.